Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy
about
Dual effects of ouabain on the regulation of proliferation and apoptosis in human umbilical vein endothelial cells: involvement of Na(+)-K(+)-ATPase α-subunits and NF-κB.Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.Neuroendocrine humoral and vascular components in the pressor pathway for brain angiotensin II: a new axis in long term blood pressure control.Why isn't endogenous ouabain more widely accepted?A new clinical multivariable model that predicts postoperative acute kidney injury: impact of endogenous ouabainEndogenous ouabain and cardiomyopathy in dialysis patientsEndogenous cardiotonic steroids in kidney failure: a review and an hypothesis.Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure.Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.Endogenous ouabain in renal Na(+) handling and related diseases.Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension.Adducin polymorphisms and the treatment of hypertension.Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.Endogenous digitalis: pathophysiologic roles and therapeutic applications.Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patientsRole of endogenous cardiotonic steroids in sodium homeostasis.The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension.The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition.Personalized Therapy of Hypertension: the Past and the Future.On the Many Actions of Ouabain: Pro-Cystogenic Effects in Autosomal Dominant Polycystic Kidney Disease.Ouabain Contributes to Kidney Damage in a Rat Model of Renal Ischemia-Reperfusion Injury.Endogenous Ouabain: Recent Advances and ControversiesHow does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial.The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system.Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.
P2860
Q33815901-6480BBC0-07E7-4B56-A599-078AFA8DB4A4Q34017477-7AFA8476-A5C9-43C7-84C5-79A8A79EF4C8Q34282179-3924C500-8334-46E8-BBE3-6FA60A15F2F1Q34296699-2A477AAB-367E-4A1B-8BEE-A31961AC11DEQ34354207-819BDE4F-1811-4389-82C5-0ACD5C712357Q34723285-72E9E6D0-6FBC-4AFB-BBDA-BAB47D159CE7Q35541172-FCFA005F-21F6-4E89-8EA6-063D92F349EBQ36296874-E63828D8-EF25-48A6-8760-E63CC30FED2CQ36391656-9A50714C-C0C8-4B74-B95D-8D42382FB7D3Q36454313-9D7600BF-23D6-48FC-88DB-039822F84600Q36456452-02765557-2F89-422B-A357-2BB74306BC34Q36804402-25C670B5-81AF-46C8-9655-C72E3C51D822Q36817975-260D4F72-25EB-44F9-B4D3-F16C45AF4F8AQ36952529-399083C8-FCD8-4813-A251-89EF31EA86CDQ37149644-129E5B05-10B4-4133-BE29-A0BF5DBF2575Q37192115-91562B61-33EA-4127-825A-8BA493C5741BQ37307933-72A6EB51-09A0-4757-BCF7-9DC4DB69C8DAQ37680502-7F5CC586-7FB5-4A17-BF64-9F0790D95578Q38749985-B74CBCCC-422C-4805-AE6D-7E20E8E1692BQ39280515-B27109A5-44F8-431B-9D15-7E436A33E568Q41613924-8EBCAD16-FB39-4053-B4C2-8A86F00127FAQ41923007-7045DA9F-60FF-4D0D-950F-247D4A44CEF0Q47894268-886315A8-51E6-47B9-82B0-B36746CD7D20Q48087140-0B9F50E6-04F1-40BD-BA70-CFA3192A7FDCQ48448938-BF78CA11-CB4D-44BC-B6AA-B6CA81EEF08E
P2860
Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy
description
article
@en
im Februar 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2006
@uk
name
Independent and incremental pr ...... opathic dilated cardiomyopathy
@en
Independent and incremental pr ...... opathic dilated cardiomyopathy
@nl
type
label
Independent and incremental pr ...... opathic dilated cardiomyopathy
@en
Independent and incremental pr ...... opathic dilated cardiomyopathy
@nl
prefLabel
Independent and incremental pr ...... opathic dilated cardiomyopathy
@en
Independent and incremental pr ...... opathic dilated cardiomyopathy
@nl
P2093
P2860
P50
P1476
Independent and incremental pr ...... opathic dilated cardiomyopathy
@en
P2093
Elisabetta Messaggio
Elisabetta de Tommasi
Giuseppe Bianchi
John M. Hamlyn
Maria Vittoria Pitzalis
Paolo Rizzon
Roberta Romito
P2860
P304
P356
10.1016/J.EJHEART.2005.07.010
P577
2006-02-20T00:00:00Z